Red2Onco, an innovative genetic mouse model, allows to detect the very initial steps that lead to cancer development. Red2Onco’s multi-colour labelling system allows to trace intestinal tumour development after the first oncogenic hit at the single cell level. The research carried out at IMBA – Institute of Molecular Biotechnology of the Austrian Academy of Sciences – and the University of Cambridge is now published in the journal Nature.
Read the full story here.